Skip to main content
Livermore
Livermore
ZHEN

Capital Analysts, LLC

SEC CIK
0001624758
Latest filing
Aug 5, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
6,203
Value
$210.0K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of TEVA by Capital Analysts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,203$210.0K<0.1%00.0%UnchangedHolders
Q1 20266,203$187.0K<0.1%00.0%UnchangedHolders
Q4 20256,203$194.0K<0.1%00.0%UnchangedHolders
Q3 20256,203$125.0K<0.1%00.0%UnchangedHolders
Q2 20256,203$104.0K<0.1%+1,061+20.6%AddedHolders
Q1 20255,142$79.0K<0.1%+526+11.4%AddedHolders
Q4 20244,616$102.0K<0.1%+4,616NewHolders
Q2 20240$00.0%−196−100.0%Sold outHolders
Q1 2024196$3.00K<0.1%00.0%UnchangedHolders
Q4 2023196$2.00K<0.1%00.0%UnchangedHolders
Q3 2023196$2.00K<0.1%00.0%UnchangedHolders
Q2 2023196$1.00K<0.1%00.0%UnchangedHolders
Q1 2023196$2.00K<0.1%00.0%UnchangedHolders
Q4 2022196$2.00K<0.1%00.0%UnchangedHolders
Q3 2022196$2.00K<0.1%00.0%UnchangedHolders
Q2 2022196$1.00K<0.1%00.0%UnchangedHolders
Q1 2022196$2.00K<0.1%00.0%UnchangedHolders
Q4 2021196$2.00K<0.1%00.0%UnchangedHolders
Q3 2021196$2.00K<0.1%00.0%UnchangedHolders
Q2 2021196$2.00K<0.1%−103−34.4%ReducedHolders
Q1 2021299$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.